Related Experiment Video
Updated: Jul 10, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Genotype-Phenotype Correlations in 293 Russian Patients with Causal Fabry Disease Variants
Kirill Savostyanov1, Alexander Pushkov1, Ilya Zhanin1
1FSAI National Medical Research Center for Children's Health of the Russian Federation Ministry of Health, Moscow 119991, Russia.
This study identified 102 cases of Fabry disease (FD) in over 50,000 patients through screening. It details 104 GLA gene variants and links lyso-Gb3 levels and specific variants to clinical manifestations like stroke.
Area of Science:
- Genetics
- Rare Diseases
- Biomarkers
Background:
- Fabry disease (FD) is a rare, inherited, multisystem disorder caused by pathogenic variants in the GLA gene.
- Genotype-phenotype correlations are crucial for understanding diverse clinical presentations of FD, including classical, atypical, late-onset, and system-specific forms.
Purpose of the Study:
- To conduct large-scale screening for Fabry disease in a Russian population.
- To identify GLA gene variants and establish genotype-phenotype and genotype-biomarker correlations.
- To describe the clinical spectrum and frequencies of manifestations in a cohort of Russian FD patients.
Main Methods:
- A two-step diagnostic algorithm was employed, starting with lyso-Gb3 biomarker concentration measurement for 48,428 high-risk individuals.
- High-throughput sequencing was used to screen 2427 additional patients with hypertrophic cardiomyopathy (HCM) for atypical FD.
- Molecular genetic testing identified GLA gene variants in 293 confirmed FD cases from 133 families.
Main Results:
- Fabry disease was detected in 102 (0.20%) of 50,855 screened patients.
- A spectrum of 104 distinct pathogenic GLA gene variants was identified in 293 patients, with detailed clinical manifestations described, including 20 pediatric cases.
- Correlations were established between lyso-Gb3 biomarker levels and specific pathogenic GLA variants, and certain variants were associated with early stroke development.
Conclusions:
- Large-scale screening effectively identified Fabry disease cases in the Russian population.
- The study provides comprehensive clinical and molecular genetic data for a significant cohort of Russian FD patients.
- Established correlations enhance understanding of FD pathogenesis and can inform diagnostic and therapeutic strategies.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
Incomplete Dominance
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pedigree Analysis
Pleiotropy
Genetic Lingo
Sex-linked Disorders